MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Intensive speech rehabilitation in degenerative ataxias improves intelligility

A. Vogel, N. Rommel, M. Synofzik (Melbourne, Australia)

Meeting: 2018 International Congress

Abstract Number: 608

Keywords: Dysarthria, Familial neurodegenerative diseases, Rehabilitation

Session Information

Date: Sunday, October 7, 2018

Session Title: Ataxia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To test the efficacy and tolerability of intensive home based treatment for dysarthria in ataxia

Background: The loss of the ability to speak is a devastating and inevitable outcome of many neurodegenerative diseases. It results in daily disadvantage, stigmatization, social marginalization and underemployment. Disordered speech is an inevitable consequence of hereditary ataxias.

Methods: We examined the efficacy of a 4-week intensive speech rehabilitation program for 20 people with progressive ataxia due to recessive cerebellar disease (i.e., Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay [ARSACS], recessive spinocerebellar ataxia [FRDA], or dominantly-inherited cerebellar ataxias [SCA]) using an intra-individual control design. The treatment protocol is based on principles of motor learning and neuroplasticity with a focus on improving speech intelligibility and vocal control. Exercises and feedback were created to enhance self-monitoring and include computer based aural, visual and results feedback and self-management. Efficacy was measured by an expert listener blinded to time-point rating intelligibility of speech samples from the study participants using Direct Magnitude Estimation. (DME). DME dictates that samples are compared to a pre-identified anchor.

Results: In these 20 participants, mean (SD) intelligibility was 98.0 (29.8) points at baseline and 119.5 (25.4) 4-weeks post-baseline with Pearson’s correlation coefficient of 0.9. The relative (%) increase in speech intelligibility from baseline to post-treatment was statistically significant (geometric mean of the post-treatment/baseline ratio 1.25, 95% CI [1.16, 1.35], p<0.0001) using a two-sided paired t-test on base-2 log-transformed outcome data. Relative improvements from baseline in intelligibility of 5-10% represent clinically meaningful change in participants’ speech including significant change in voice quality and naturalness in a variety of tasks (eg. conversation). We saw individual relative increases in intelligibility between -7-80% in our pilot data. On an individual level, 16/17 (94%) patients responded to treatment.

Conclusions: Our preliminary speech rehabilitation data has yielded promising results. Our pilot data shows that even mild dysarthria improves with our intervention. The relative improvement is larger for those ataxia participants (SCA) with more severe dysarthria. A larger trial has been initiated.

To cite this abstract in AMA style:

A. Vogel, N. Rommel, M. Synofzik. Intensive speech rehabilitation in degenerative ataxias improves intelligility [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/intensive-speech-rehabilitation-in-degenerative-ataxias-improves-intelligility/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/intensive-speech-rehabilitation-in-degenerative-ataxias-improves-intelligility/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley